ALOX5 and colonic neoplasm: Blockade of 5-LOX or its downstream products (in particular LTB4) reduced colonic cancer cells proliferation both in vitro and in vivo, indicating that 5-LOX inhibitor may represent a promising candidate chemopreventive agent for colon cancer treatment [79], [80], [81].